Marijuana Could Be Key in Curing Alzheimer’s Disease
This article originally appeared at https://bigthink.com/health/marijuana-may-be-key-in-curing-alzheimers-find-researchers/ Researchers find that a compound within marijuana may potentially protect from the onset of Alzheimer’s disease. In news that might be counterintuitive to the common experience of how weed affects memory, researchers have shown that marijuana could have potential in treating Alzheimer’s disease. In particular, scientists from Salk Institute in […]
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
This article originally appeared at https://jpet.aspetjournals.org/content/318/3/1375 Authors: Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, Isabel Matias, Simona Pisanti, Luciano De Petrocellis, Chiara Laezza, Giuseppe Portella, Maurizio Bifulco and Vincenzo Di Marzo Journal of Pharmacology and Experimental Therapeutics September 2006, 318 (3) 1375-1387; DOI: https://doi.org/10.1124/jpet.106.105247
Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response
This article originally appeared at https://jpet.aspetjournals.org/content/377/2/273 Authors: Bárbara Betônico Berg, Jaqueline Silva Soares, Isabela Ribeiro Paiva, Barbara Maximino Rezende, Milene Alvarenga Rachid, Stêfany Bruno de Assis Cau, Thiago Roberto Lima Romero, Vanessa Pinho, Mauro Martins Teixeira and Marina Gomes Miranda e Castor Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 273-283; DOI: https://doi.org/10.1124/jpet.120.000479 Abstract Cannabidiol (CBD) is a highly lipidic phytocannabinoid with remarkable anti-inflammatory effects. The aim of […]
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells
This article originally appeared at https://gut.bmj.com/content/54/12/1741.abstract Authors: Abstract Background and aims: Cyclooxygenase 2 (COX-2) is upregulated in most colorectal cancers and is responsible for metabolism of the endogenous cannabinoid, anandamide, into prostaglandin-ethanolamides (PG-EAs). The aims of this study were to determine whether anandamide and PG-EAs induce cell death in colorectal carcinoma (CRC) cells, and whether high […]
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
This article originally appeared at https://www.pnas.org/doi/abs/10.1073/pnas.95.14.8375 Authors: Luciano De Petrocellis, Dominique Melck, Antonella Palmisano, +3, and Vincenzo Di MarzoAuthors Info & Affiliations July 7, 1998 https://doi.org/10.1073/pnas.95.14.8375 Abstract Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro. […]
Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
This article originally appeared at https://www.jneurosci.org/content/25/8/1904.abstract Authors: Belén G. Ramírez, Cristina Blázquez, Teresa Gómez del Pulgar, Manuel Guzmán and María L. de Ceballos Journal of Neuroscience 23 February 2005, 25 (8) 1904-1913; DOI: https://doi.org/10.1523/JNEUROSCI.4540-04.2005 Abstract Alzheimer’s disease (AD) is characterized by enhanced β-amyloid peptide (βA) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits. Cannabinoids are neuroprotective agents against excitotoxicity in […]
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
This article originally appeared at https://www.pnas.org/doi/full/10.1073/pnas.160105897 Authors: A. M. Malfait, R. Gallily, P. F. Sumariwalla, +3, and M. FeldmannAuthors Info & Affiliations August 1, 2000 https://doi.org/10.1073/pnas.160105897 Abstract The therapeutic potential of cannabidiol (CBD), the major nonpsychoactive component of cannabis, was explored in murine collagen-induced arthritis (CIA). CIA was elicited by immunizing DBA/1 mice with type II collagen (CII) in complete Freund’s adjuvant. The […]
CHRONIC ADMINISTRATION OF CANNABIDIOL TO HEALTHY VOLUNTEERS AND EPILEPTIC PATIENTS
Pharmacology 21: 175-185 (1980) Jomar M. Cunha, E.A. Carlini, Aparecido E. Pereira, Oswaldo L. Ramos,Camilo Pimentel, Rubens Gagliardi, W.L. Sanvito, N. Lander and R. Mechoulam Departments de Psicobiologia, Departamento de Medicina, Departamento deNeurologia, Escola Paulista de Medicina; Departamento de Neurologia,Faculdade de Medicina da Santa Case, Sao Paulo, [Brazil] and Department ofNatural Products, Pharmacy School, Hebrew […]
Analysis of Online Forum Discussions on Cannabis Use and ADHD
This article originally appeared at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614 “I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD Background Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for problematic cannabis use. However, clinical and anecdotal evidence suggest an increasingly popular perception that cannabis is therapeutic for ADHD, including via online […]
Clinical outcome analysis of patients with autism spectrum disorder
This article originally appeared at https://journals.sagepub.com/doi/full/10.1177/20451253221116240 Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical evidence of their efficacy and safety. Objective: This case series aims to assess changes to health-related quality of life […]
